A carregar...
Potential for Developing Purinergic Drugs for Gastrointestinal Diseases
Treatments for IBD, IBS, FD or motility disorders are not adequate, and purinergic drugs offer exciting new possibilities. GI symptoms that could be targeted for therapy include visceral pain, inflammatory pain, dysmotility, constipation and diarrhea. The focus of this review is on potential for dev...
Na minha lista:
| Publicado no: | Inflamm Bowel Dis |
|---|---|
| Main Authors: | , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
2014
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4340257/ https://ncbi.nlm.nih.gov/pubmed/24859298 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/MIB.0000000000000047 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|